Reversible paroxetine-induced symptomatic hypothyroidism.

Reversible paroxetine-induced symptomatic hypothyroidism. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Reversible paroxetine-induced symptomatic hypothyroidism. Abstract Text:

M Takahashi,E Sawayama,T Sawayama,H Miyaoka,

Reversible paroxetine-induced symptomatic hypothyroidism. Publishing Authors By Initials

M Takahashi,E Sawayama,T Sawayama,H Miyaoka,

For similar hormones, hormone substitutes, and hormone antagonists: hormones: thyroid hormones research abstracts see: hormones, hormone substitutes, and hormone antagonists: hormones: thyroid hormones research

PUBMED ID PMID:

MEDLINE DATE:

Reversible paroxetine-induced symptomatic hypothyroidism. Journal Published:

PUBLICATION TYPE: Letter

Journal: Pharmacopsychiatry

VOLUME: 40

Page Numbers: 201-2

Journal Abbreviation: Pharmacopsychiatry

ISSN: 0176-3679

DAY: 20

MONTH: Sep

YEAR: 2007

Reversible paroxetine-induced symptomatic hypothyroidism. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8402938

Reversible paroxetine-induced symptomatic hypothyroidism. Keywords Mesh Terms:

KEYWORDS: Thyroid Hormones

MESH TERMS: blood

Chemical & Substance for Abstract: Reversible paroxetine-induced symptomatic hypothyroidism. Information

Substance Name: Paroxetine

Registry Number: 61869-08-7

Grant and Affiliation Information for Reversible paroxetine-induced symptomatic hypothyroidism.

AFFILIATION:

Country: Germany

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Pharmacopsychiatry

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Reversible paroxetine-induced symptomatic hypothyroidism Related Publications

• A Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancers.
• A new method of simulating surface electromyograms using probability density functions.
• Depth of interaction decoding of a continuous crystal detector module.
• Moderate hyperventilation prolongs electroencephalogram seizure duration of the first electroconvulsive therapy.
• Oral perception of bolus in healthy young women.
• Parametric positioning of a continuous crystal PET detector with depth of interaction decoding.
• Plasma nitrate levels in deficit versus non-deficit forms of schizophrenia.
• Poor performance in Clock-Drawing Test associated with visual memory deficit and reduced bilateral hippocampal and left temporoparietal regional blood flows in Alzheimer's disease patients.
• Prognosis of resected non-small cell lung cancer patients with intrapulmonary metastases.
• Reversible paroxetine-induced symptomatic hypothyroidism.
• Somatosensory disturbance by methylmercury exposure.
• The relationship between patient characteristics and psychiatric day care outcomes in schizophrenic patients.